الإعلام
Biotricity Inc. (Biotricity) announces its inclusion as a supplier to another major medical system that encompasses 60,000 care providers over 400 hospitals and 400 care centers. This partnership not only expands Biotricity’s market reach but also underscores its commitment to addressing critical gaps in cardiovascular care across the nation.
Biotricity Inc. (Biotricity) announces the launch of a new cardiac monitoring pilot program with a top hospital system. With 90% of U.S. adults at risk of developing cardiovascular disease and a projected shortage of up to 124K physicians in the next 12 years, the demand for Biotricity’s innovative cardiac monitoring solutions has never been more urgent. Integration of Biotricity’s advanced cardiac monitoring solutions into major hospitals will poise the company to play a crucial role in reshaping how cardiovascular health and other chronic diseases are managed.
Biotricity Inc. (Biotricity) today announced ongoing improvements in operational efficiency, scalability and margin performance driven by the latest enhancements to the company’s proprietary AI Cloud platform. The latest version of Biotricity’s AI Cloud has improved the company’s tech stack efficiency by 20%, which is expected to result in a topline margin improvement of 200 to 300 basis points (2 to 3%) in the coming quarters. The next version of the AI Cloud, currently under development, is anticipated to enhance the tech stack by another 20%, contributing to an additional margin improvement of 100 to 200 basis points (1 to 2%). These across-the-board improvements are accelerating Biotricity’s path to breakeven and achieving positive cash flow.
Biotricity Inc. (Biotricity) today announced its accelerated timeline to achieving EBITDA positive. The company now expects to reach this significant milestone before the end of calendar 2024, earlier than previously anticipated.
Biotricity Inc. (Biotricity) today announced the launch of a new cardiac monitoring pilot program with a prominent hospital group encompassing 60 sites spread across multiple states. Biotricity’s cardiac monitoring solution is the only three-channel connected solution in the world. This unique technology results in superior diagnostics, reduced patient risk, and enhanced workflow efficiency, providing improved clinical outcomes while lowering overall healthcare costs.
Biotricity Inc. (Biotricity) today announces the highly anticipated launch of its direct-to-consumer heart health screening program, HeartSecure. HeartSecure represents a monumental leap forward in cardiac monitoring, providing users with unparalleled convenience, affordability, and peace of mind. By increasing access to heart monitoring and empowering individuals to take control of their cardiac health, Biotricity is helping reshape cardiac care.
